ARCHIVES

FDA to refer false statements by regulated companies to SEC.

This article is from The Cancer Letter archive.

Vol. 30 No. 09 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

Also Weber returns to M.D. Anderson.

August 8, 2003

Univ. Of Pittsburg Vows To Make Changes To Keep NSABP

April 8, 1994

NCI Grant To Help Pitt Include Teaching End-of-Life Issues.

July 6, 2001

DCCP Board Okays Concepts For Severn Contract Recompetitions, Denies Two Other

June 19, 1981

Women With Least Aggressive Subtype of Breast Cancer Still at Risk After 10 Years

September 28, 2012

Cancer & The Media: Klausner, Watson Dispute Comments In New York Times Story

May 8, 1998